Updates are available Correction dated 2019-02-25
Click to view Correction: https://doi.org/10.1007/s00198-019-04877-z
-
Authors
Ong, K. L.
Beall, D. P.
Frohbergh, M.
Lau, E.
Hirsch, J. A.
-
Funding
Funding for this research was provided by:
Medtronic
- License Information
-
More Information
Article History
Received: 28 August 2017
Accepted: 17 October 2017
First Online: 24 October 2017
Change Date: 25 February 2019
Change Type: Correction
Change Date: 25 February 2019
Change Type: Correction
Change Details: The articleWere VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty ���sham��� trials?,written by K. L. Ong, D. P. Beall, M. Frohbergh, E. Lau, and J. A. Hirsch was originally published electronically on the publisher���s internet portal.
Change Details: The articleWere VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty ���sham��� trials?,written by K. L. Ong, D. P. Beall, M. Frohbergh, E. Lau, and J. A. Hirsch was originally published electronically on the publisher���s internet portal.
Compliance with ethical standards
:
: KLO, EL, MF: employees of Exponent, Inc., a scientific and engineering consulting firm.KLO: Exponent has been paid fees by companies and suppliers for my consulting services on behalf of such companies and suppliers (Stryker Orthopaedics, Zimmer Biomet, Ethicon, Ferring Pharmaceuticals, Paradigm Spine, Medtronic, Pacira Pharmaceuticals, DJO, Ossur).JAH: direct fees consulting (Medtronic; Globus (one-time fee)); Codman Neurovascular Data and Safety Monitoring Board participation.DPB: Benvenue: paid consultant; paid presenter or speaker; stock or stock options.Lilly: paid presenter or speaker.Lilly, Amendia, Medtronic: board or committee member; paid consultant; research support; stock or stock options.Medtronic: paid presenter or speaker.SIR: board or committee member.Vexim: board or committee member; stock or stock options.EL: Exponent has been paid fees by companies and suppliers for my consulting services onbehalf of such companies and suppliers (Stryker Orthopaedics, Ferring Pharmaceuticals, Medtronic, CeramTec).
: This study was based on publicly available data sets, did not use private health identifiable information, and did not represent human subject research, and therefore did not require oversight by our institutional review boards.The manuscript does not contain any studies with human participants or animals performed by any of the authors. For this type of retrospective study, formal consent is not required.
